Syros Pharmaceuticals Inc (SYRS)
0.2743
-0.09
(-23.78%)
USD |
NASDAQ |
Nov 14, 16:00
0.2837
+0.01
(+3.43%)
After-Hours: 18:20
Syros Pharmaceuticals Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.386M |
| September 30, 2023 | 3.762M |
| June 30, 2023 | 2.833M |
| March 31, 2023 | 2.954M |
| December 31, 2022 | -0.754M |
| September 30, 2022 | 3.891M |
| June 30, 2022 | 6.276M |
| March 31, 2022 | 5.467M |
| December 31, 2021 | 7.802M |
| September 30, 2021 | 5.697M |
| June 30, 2021 | 5.162M |
| March 31, 2021 | 4.827M |
| December 31, 2020 | 5.699M |
| September 30, 2020 | 3.828M |
| June 30, 2020 | 3.188M |
| March 31, 2020 | 2.379M |
| December 31, 2019 | 0.508M |
| September 30, 2019 | 0.558M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.462M |
| March 31, 2019 | 0.454M |
| December 31, 2018 | 0.893M |
| September 30, 2018 | 0.412M |
| June 30, 2018 | 0.375M |
| March 31, 2018 | 0.37M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 1.101M |
| December 31, 2016 | 0.317M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 0.317M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.754M
Minimum
Dec 2022
7.802M
Maximum
Dec 2021
3.759M
Average
3.828M
Median
Sep 2020
Revenue (Quarterly) Benchmarks
| Baxter International Inc | 2.699B |
| AbbVie Inc | 14.46B |
| Elanco Animal Health Inc | 1.03B |
| Opus Genetics Inc | 1.112M |
| Entrada Therapeutics Inc | 19.57M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.396M |
| Total Expenses (Quarterly) | 26.18M |
| EPS Diluted (Quarterly) | -0.16 |
| Enterprise Value | -7.537M |
| Earnings Yield | -1.12K% |
| Normalized Earnings Yield | -1622.81 |